Epstein-Barr virus infection and immunoregulation in man.
Tosato
G
G
Blaese
R M
RM
D000117:Acetylglucosamine / Q000494:pharmacology; D000917:Antibody Formation; D000921:Antibody-Producing Cells / Q000382:microbiology; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000382:microbiology; D001402:B-Lymphocytes / Q000382:microbiology*; D002470:Cell Survival; D002999:Clone Cells / Q000382:microbiology; D003602:Cytotoxicity, Immunologic; D006566:Herpesviridae Infections / Q000382:microbiology; D004854:Herpesvirus 4, Human / Q000472:pathogenicity*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007244:Infectious Mononucleosis / Q000382:microbiology; D008232:Lymphoproliferative Disorders / Q000276:immunology / Q000382:microbiology*; D008358:Mannose / Q000494:pharmacology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D008358:Mannose; D000117:Acetylglucosamine